Anti-Diabetic and Antibiotic Study of Chromon-3-Ylidine 2,4 ...

REFERENCES

171

REFERENCES

Adler, A. I. (2008) UKPDS-modelling of cardiovascular risk assessment and lifetime

simulation of outcomes. Diabetes Med., 25: 41-46.

Ahn, J. H., Kim, S. J., Park, W. S., Cho, S.Y., Ha, J. D., Kim, S. S., Kang, S. K.,

Jeong, D. G., Jung, S. -K., Lee, S.-H., Kim, H. M., Park, S. K., Lee, K. H.,

Lee, C. W., Ryu, S. E. and Choi, J. -K. (2006) Synthesis and biological

evaluation of rhodanine derivatives as PRL-3 inhibitors Bioorg. & Med.

Chem. Lett., 16: 2996–2999.

Akagawa, K., Akabane, H., Sakamoto, S. and Kudo K. (2009) Asymmetric transfer

hydrogenation in aqueous media catalyzed by resin-supported peptide having

a polyleucine tether Tetrahedron: Asymm., 20: 461-466.

Akagawa, K., Akabane, H., Sakamoto, S. and Kudo, K. (2008) Organocatalytic

Asymmetric Transfer Hydrogenation in Aqueous Media Using Resin-

Supported Peptide Having a Polyleucine Org. Lett., 10: 2035-2037.

Akbari, J. D., Tala, S. D., Dhaduk, M. F. and Joshi, H. S. (2008) Molecular iodine-

catalyzed one-pot synthesis of some new Hantzsch 1,4-dihydropyridines at

ambient temperature. Arkivoc, Xii: 126-135.

Alagawadi, K. R. and Alegaon S. G. (2011) Synthesis, characterization and

antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing

imidazo[2,1-b][1,3,4]thiadiazole moiety. Arab. J. Chem., 4: 465–472.

Alanis, A. (2005) Resistance to antibiotics: are we in the post-antibiotic era?. Arch.

Med. Res., 36: 697-705.

172

Allan, F. J. and Allan, G. G. (1961) The condensation of rhodanine and derivatives

with 4-antipyrinaldehyde. Can. J. Chem., 39: 1397–1399.


with aromatic aldehydes containing iodine. Recl. Trav. Chim. Pays Bas, 82:

177–181.


with some indole aldehydes. Monatsh. Chem., 94: 1434–4475, [Chem. Abstr.

1963, 59, 48312].

Allan, F. J. and Allan, G. G. (1964) Izoxazolylmethylenerhodanines. Recl. Trav.

Chim. Pays Bas, 83: 1299–1300.

Allan, F. J., Allan, G. G. and Thompson, J. B. (1961) The condensation of rhodanine

and derivatives with pyridine and quinoline aldehydes. Recl. Trav. Chim. Pays

Bas, 80: 403–408.

Allan, F. J., Allan, G. G., Crank, G. and Jack, J. (1960) The condensation of

rhodanine and derivatives with benzaldehyde sulphonic acids. Recl. Trav.

Chim. Pays Bas, 79: 247–254.

American Diabetes Association. Diagnosis and classification of diabetes mellitus.

(2009) Diabetes Care, 32: 62-67.

American Diabetes Association. Diagnosis and classification of diabetes mellitus.

(2011) Diabetes Care, 34: 62-69.

American Diabetes Association. Implications of the Diabetes Control and

Complications Trial. (1993) Diabetes, 42: 1555-1558.

173

American Diabetes Association. Report of the expert committee on the diagnosis and

classification of diabetes mellitus. (2003) Diabetes Care, 26: 5-20.

American Diabetic Association (1993) Diabetes, 43: 1555-1558.

Anastas, P.T. and Lankey, R.L. (2000) Life Cycle Assessment and Green Chemistry:

The Yin and Yang of Industrial Ecology. Green Chem., 2: 289-295.

Anastas, P.T. and Warner, J.C. (1998) Green Chemistry: Theory and Practice, Oxford

University Press: New York, 30.

Anastas, P.T., Heine, L.G. and Williamson, T.C. (2000) Green Chemical Syntheses

Processes: Introduction, American Chemical Society: Washington, DC,

Chapter 1.

Andreani, A., Rambaldi, M., Locatelli, A., Leoni, R., Bossa, M., Chiericozzi, I.,

Alatulas, G. and Salvatore, A. (1993) Synthesis of lactams with potential

cardiotonic activity. Eur. J. Med. Chem., 28: 825-829.

Andreasch, R. (1908) Substituted rhodaninic acids and their aldehyde condensation

products. VII. Monatsh. Chem., 29: 399–419, [Chem. Abstr. 1908, 2, 14948].

ArRajab, A. and Ahren, B. (1993) Long term diabetogenic effect of streptozotocin in

rat. Pancreas. Pancreas, 8: 50-57.

Babu, J., Khare, A. and Vankar, Y. (2005) Bi(OTf)3 and SiO2-Bi(OTf)3 as Effective

Catalysts for the Ferrier Rearrangement. Molecules, 10: 884-892.

Babu, T. H., Shanthi, G. and Perumal, P. T. (2009) A facile one-pot synthesis of N-

substituted tetrahydroquinolines Tetrahedron Lett., 50: 2881-2884.

174

Bandyopadhyay, C., Sur, K. R. and Patra, R. (2002) Zinc-Induced Reduction of Ethyl

2-Cyano-3-(4-oxo-4H-1-benzopyran-3-yl)propenoates-A Medium-Dependent

Reaction. J. Chem. Res. Synop., 9: 414-415.

Bandyopadhyay, C., Sur, K. R., Patra, R. and Sen, A. (2000) Sodium Naphthalenide-

Induced Conversion of 3-Methoxycarbonyl-4-oxo-4H-1-benzopyran (I) into 4-

Hydroxy-3-salicyloylxanthone (II). J. Chem. Res. Synop., 468-469.

Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. and Fletcher, A. A. (1922)

Pancreatic extracts in the treatment of diabetes mellitus. Canad. Med. Asso. J.,

12: 141-146.

Baranov, S.N. (1961) Zhur. Obshch. Khim., 2: 512-518.

Barbe, G. and Charette, A. B. (2008) Highly Chemoselective Metal-Free Reduction

of Tertiary Amides. J. Am. Chem. Soc., 130: 18-19.

Barros, C. D., Amato, A. A., Oliveira, T. B. de., Iannini, K. B. R., Silva, A. L. da.,

Silva, T. G. da., Leite, E. S., Hernandes, M. Z., Lima, M. do C. A. de.,

Galdino, S. L., Neves, F. de A. R. and Pitta, I. da R. (2010) Synthesis and anti-

inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ

ligands. Bioorg. & Med. Chem., 18: 3805–3811

Baruah, A. K., Prajapati, D. and Sandhu, J. S. (1987) Studies on chromone

derivatives. Novel 1,3 dipolar cycloadditions of 4-oxo-1-benzopyran-3-

carbaldehyde imines and imine oxides J. Chem. Soc., Perkin Trans 1., 1995-

1998.

Baruah, A. K., Prajapati, D. and Sandhu, J. S. (1988) Studies in chromone derivatives

: cycloaddition reactions of 4-oxo 4H-1-benzopyran -3-carboxaldehyde imines

175

with benzonitrile oxide and nitrilimine of 4-oxo-4H-1 benzopyran -3-

carboxalde with alkanes. Tetrahedron, 44: 1241-1246.

Baruah, P. P., Gadhwal, S., Prajapati, D. and Sandhu, J. S. (2002) The Biginelli

Condensation: A Novel and Efficient Regioselective Synthesis of

Dihydropyrimidin-2(1H)-ones Using Lithium Bromide. Chem. Lett., 1038-

1039.

Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee,

R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., Nicholson,

W. K., Hutfless, S., Bass, E. B. and Bolen, S. (2011) Adults With Type 2

Diabetes: An Update. Comparative Effectiveness Review No. 27. March 2011

(Prepared by Johns Hopkins University Evidence-based Practice Center under

Contract No. 290-02-0018.) AHRQ Publication No. 11-EHC038-EF.

Rockville, MD: Agency for Healthcare Research and Quality. Available at:

www.effectivehealthcare.ahrq.gov/reports/final.cfm.

Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee,

R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., Nicholson,

W. K., Hutfless, S., Bass, E. B. and Bolen, S. (2011) Ann. Int. Med. (May 3

2011) Web published in advance of print publication, March 14.

Berson, J. A. and Brown, E. (1955) Studies on dihydropyridines. I. The preparation of

unsymmetrical 4-aryl-1,4-dihydropyridines by the Hantzsch-Beyer synthesis

J. Am. Chem. Soc., 77: 444-447.

Bhattarai, B. R., Kafle, B., Hwang, J. -S., Ham, S. W., Lee, K. -H., Park, H., Han, I. -

O. and Cho, H. (2010) Novel thiazolidinedione derivatives with anti-obesity

176

effects: Dual action as PTP1B inhibitors and PPAR-γ activators. Bioorg. &

Med. Chem., 20: 6758–6763.

Bhattarai, B. R., Kafle, B., Hwang, J. -S., Khadka, D., Lee, S. -M., Kang, J. -S.,

Hamd, S. W., Han, I. -O., Park, H. and Cho, H. (2009) Thiazolidinedione

derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity

effects. Bioorg. & Med. Chem. , 19: 6161–6165.

Bhatti, R. S., Krishan, P., Suresh and Sandhu, J. S. (2010) Bismuth trichloride – A

clean, green catalyst for the synthesis of Hantzsch 1,4-dihydropyridines

(DHPs). J. Indian Chem. Soc., 87: 707-710,

Boer, R. and Gekeler, V. (1995) Chemosensitizers in tumor therapy: new compounds

promise better efficacy Drugs Fut., 20: 499-509.

Bosch, F. and Rosich, L. (2008) The Contributions of Paul Ehrlich to Pharmacology:

A Tribute on the Occasion of the Centenary of His Nobel Prize.

Pharmacology, 82: 171–179.

Bossert, F., Meyer, H. and Wehinger, E. (1981) 4-Aryldihydropyridines, a new class

of highly active calcium antagonists. Angew. Chem. Int. Ed. Engl., 20: 762-

769,

Boyd, D. B. (1997) On the rhodanines and their presence in biologically active

ligands. J. Mol. Struct. Theochem., 401: 227–234.

Braude, E. A., Hannah, J. and Linstead, R. (1960) Hydrogen transfer. Part XVII.

Homogeneous hydrogen transfer reactions from dihydrides of nitrogenous

heterocycles to miscellaneous acceptors. J. Chem. Soc., 3257-3267.

Briukhanov, V. M. and Zverev-Iaf Elkin, V. I. (1994) The effect of calcium

177

antagonists on the development of inflammatory edema in rats Exp. clin.

Pharrnacol., 57: 47-49.

Briukhanov, V. M. and Zverev-laf Elkin, V. I. (1994) The effect of calcium

antagonists on the development of inflammatory edema in rats. Exp. Clin.

Pharmacol., 57: 47-49.

Brogan, A. P., Dickerson, T. J. and Janda, K. D. (2007) Nornicotine-organocatalyzed

aqueous reduction of alpha, beta-unsaturated aldehydes Chem. Commun.,

4952-4954.

Bruna, G., Costantino, L., Curinga, C., Maccari, R., Monforte, F., Nicolo, F., Ottana,

R. and Vigorita, M. G. (2002) Synthesis and aldose reductase inhibitory

activity of 5-arylidene-2,4-thiazolidinediones. Bioorg. Med. Chem. Lett., 12:

1077-1084.

Calderon, C. B. and Sabundayo, B. P. (2007) Antimicrobial Classifications: Drugs

for Bugs. In Schwalbe, R., Steele-Moore, L. and Goodwin, A. C.

Antimicrobial Susceptibility Testing Protocols. CRC Press. Taylor & Frances

group.

Campbell, S. F., Cross, P. E., Burges, R. A., Carter, A. J. and Gardiner, D. G. (1989)

Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-

activity relationships for a series of 2-[(heterocyclylmethoxy)methyl]

derivatives. J. Med. Chem., 32: 2381-2388.

Cantello, B. C., Cawthorne, M. A., Cottam, G. P., Duff, P. T., Haigh, D., Hindley, R.

M., Lister, C. A., Smith, S. A. and Thurlby, P. L. (1994) [[omega-

178

(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent

antihyperglycemic agents. J. Med. Chem., 37: 3977-3985.

Captan, G., Ulusoy, N., Ergenc, N., Ekinic, A. C. and Vidin, A. (1996) Il Farmaco,

51: 729-, Chem. Abstr., 1996, 126, 157436q.

Chai, L, Zhao, Y., Sheng, D. and Liu, Z.-Q. (2006) Aromatization of Hantzsch 1,4-

Dihydropyridines and 1,3,5-Trisubstituted Pyra- zolines with HIO3 and I2O5 in

water. Tetrahydron Lett., 47: 9283-9285.

Chang, A. Y., Wyse, B. M., Gilchrist, B. J., Peterson, T. and Diani A. R. (1983)

Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice,

diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.

Diabetes, 32: 830-838.

Chauhan, P., Kaur, K., Bala, N., Kumar, V. and Chimni, S. S. (2011) Catalyst-Free

and Solventless Hantzsch Ester Mediated Reduction of Nitroolefins at

Elevated Temperature. Ind. J. Chem., 50B: 304-309.

Chavan, S. P., Kharul, R. K., Kalkota, U. R. and Shivakumar, I. (2003) An Efficient

Co(II) Catalyzed Auto Oxidation of 1,4-Dihydropyridines Synth. Commun.,

33: 1333-1337.

Che, J. and Lam, Y. (2010) Rapid and Regioselective Hydrogenation of α,β-

Unsaturated Ketones and Alkylidene Malonic Diesters Using Hantzsch Ester

Catalyzed by Titanium Tetrachloride. Synlett, 2415-2420.

Chea, J. and Lama, Y. (2010) Polymer-Supported Hantzsch 1,4-Dihydropyridine

Ester: An Efficient Biomimetic Hydrogen Source for the Reduction of

179

Ketimines and Electron-Withdrawing Group Conjugated Olefins. Adv. Synth.

Catal., 352:1752-1758.

Chen, Z.-H., Zheng, C.-Ji., Sun, L.-P. and Piao, H.-R. (2010) Synthesis of new

chalcone derivatives containing a rhodanine-3-acetic acid moiety with

potential anti-bacterial activity Eur. J. Med. Chem., 45: 5739-5743

Clark, D. A., Goldstein, S. W., Volkmann, R. A., Eggler, J. F., Holland, G. F., Hulin,

B., Stevenson, R. W., Kreutter, D. K., Gibbs, E. M., Krupp, M. N., Merrigan,

P., Kelbaugh, P. L., Andrews, E. G., Tickner, D. L., Suleske, R. T., Lamphere,

C. H., Rajeckas, F. J., Kappeler, W. H., McDermott, R. E., Hutson, N. J. and

Johnson, M. R. (1991) Substituted Dihydrobenzopyran and

Dihydrobenzofuran Thiazolidine-2,4- diones as Hypoglycemic Agents. J.

Med. Chem., 34: 319-325.

Cobb, J. E., Blanchard, S. G., Boswell, E. G., Brown, K. K., Charifson, P. S., Cooper,

J. P., Collins, J. L., Dezube, M., Henke, B. R., Hull-Ryde, E. A., Lake, D. H.,

Lenhard, J. M., Oliver, W. Jr., Oplinger, J., Pentti, M., Parks, D. J., Plunket,

K. D. and Tong, W. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARç Agonists.

3. Relationship and Optimization of the N-Aryl Substituent. J. Med. Chem.,

41: 5055-5069.

Collins, J. L., Blanchard, S. G., Boswell, G. E., Charifson, P. S., Cobb, J. E., Henke,

B. R., Hull-Ryde, E. A., Kazmierski, W. M., Lake, D. H., Leesnitzer, L. M.,

Lehmann, J., Lenhard, J. M., Orband-Miller, L. A., Gray-Nunez, Y., Parks, D.

J., Plunkett, K. D. and Tong, W. (1998) N-(2-Benzoylphenyl)-L-tyrosine

180

PPARgamma agonists. 2. Structure-activity relationship and optimization of

the phenyl alkyl ether moiety. J. Med. Chem., 41: 5037-5054.

Colson, A. (2008) The anitibiotic pipeline. In Policy responses to the growing threat

of antibiotic resistance, Robert Wood Johnson Foundation: Princeton, NJ, Vol.

Policy Brief 6.

Connon, S. J. (2007) Asymmetric organocatalytic reductions mediated by

dihydropyridines Org. Biomol. Chem., 5: 3407-3417.

Cooper, K., Fray, M. J. and Parry, M. J. (1992) 1,4-Dihydropyridines as antagonists

of platelet activating factor. 1. Synthesis and structure-activity relationships of

2-(4-heterocyclyl)phenyl derivatives. J. Med. Chem., 35: 3115-3129.

Corma, A., Forne, V., Martin-Aranda, R. M., Garcia, H. and Primo, J. (1990) Zeolites

as base catalysts: Condensation of aldehydes with derivatives of malonic

esters. J. Appl. Catal., 59: 237-248.

Cozzi, P., Cargamico, G., Fuser, D., Grossomi, M., Menichincheri, M., Pinciroli, V.,

Vaghi, F. and Salvati, P. (1993) Imidazol-1-yl and pyridin-3-yl derivatives of

4-phenyl-1,4-dihydropyridines combining Ca2+

antagonism and thromboxane

A2 synthase inhibition. J. Med. Chem., 36: 2964-2972.

Cunha, B. A. (2009) Antibiotic Essentials. Jones & Bartlett Learning, p. 180.

Cutshall, N. S., O’Day, C. and Prezhdo, M. (2005) Rhodanine derivatives as

inhibitors of JSP-1. Bioorg. & Med. Chem. Lett., 15: 3374–3379.

Daneman, D. (2006) Type 1 diabetes. The Lancet, 367: 847-858.

DeFronzo, R. A. (1988) Lilly Lecture: The triumvirate: β-cell, muscle, liver: a

collusion responsible for NIDDM. Diabetes, 37: 667-687.

181

Dehghanpour, S., Heravi, M. M. and Derikvand, F. (2007) N,N’-

Ethylenebis(benzoylacetoniminato) Copper (II), Cu(C22H22N2O2), a New

Reagent for Aromatization of Hantzsch 1,4-Dihydropyridines Molecules, 12:

433-438.

DeLima, M.C.A., Costa, D.L.B., Goes, A.J.S., Galdino, S.L., Pitta, I.R. and Luu-Duc,

C. (1992) Synthesis and antimicrobial activity of chlorobenzyl benzylidene

imidazolidinedione derivatives and substituted thiazolidinediones. Pharmazie,

47: 182-184.

Desai, B., Sureja, D., Naliapara, Y., Shah, A. and Saxena, A. K. (2001) Synthesis and

QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted

phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.

Bioorg. Med. Chem., 9: 1993-1998.

Despres, J. P., Lamarcha, B., Mauriege, P., Cantin, B., Dagenais, G. R., Moorjani, S.

and Lupien, P.-J. (1996) Hyperinsulinemia as an independent risk factor for

ischemic heart disease. N. Engl. J. Med., 334: 952-957.

Dittmer, D. C. and Kolyer, J. M. (1962) Hydrogen Transfers from 1-Substituted

Dihydropyridines. I. Reduction of Nitro Groups. J. Org. Chem., 27: 56-60.

Dorman, S. E. and Chaisson, R. E. (2007) From magic bullets back to the magic

mountain: the rise of extensively drug-resistant tuberculosis. Nat. Med., 13:

295-298.

Dovlatyan, V. V. and Avetisyan, F. V. (1973) 2-Thioxo-4-imino(oxo)-1,3-thiazolidin-

3-ylacetic acid and its alkyl esters. Armyanskii Khim. Zh., 26: 494–498,

[Chem. Abstr. 1973, 79: 115482].

182

Dundar, O. B., Evranos, B., Evcimen, N. D., Sarıkaya, M. and Ertan, R. (2008)

Synthesis and aldose reductase inhibitory activity of some new chromonyl-

2,4-thiazolidinediones. Eur. J. Med. Chem., 43: 2412-2417.

Dunn, J. S., Sheehan, H. L. and McLetchie, N. G. B. (1943) Necrosis of the Islets of

Langerhans Produced Experimentally, Lancet, 1: 484-487.

Eisner, U. and Kuthan, J. (1972) The chemistry of dihydropyridines. Chem. Rev., 72:

1-42.

El-Feky, S.A.H. (1993) Synthesis and anticonvulsant properties of some novel

quinazolinone thiazolidine and 4-thiazolidone derivatives. Pharmazie, 48:

894-896.

Engelmann, E. (1885) Ueber die Einwirkung von Homologen des Acetaldehyds und

Ammoniak auf Acetessigäther (resp. Benzoylessigäther). Ann. Chem., 231:

37-71.

Esswein, A., Schaefer, W., Tsaklakidis, C., Honold, K. and Kaluza, K. (2003)

Rhodanine carboxylic acid derivatives for the treatment and prevention of

metabolic bone disorders. US Pat. App. 2003032813.

Esswein, A., Schaefer, W., Tsaklakidis, C., Honold, K. and Kaluza, K. (2004)

Rhodanine carboxylic acid derivatives for the treatment and prevention of

metabolic bone disorders. US Pat. App. 6673816.

Falagas, M. E. (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-

negative bacteria. BMC Infect. Dis., 5: 24.

183

Falagas, M. E. and Bliziotis, I. A. (2007) Pandrug-resistant Gram-negative bacteria:

232 the dawn of the post-antibiotic era?. Int. J. Antimicrob. Agents, 29: 630-

636.

Fang, X-Q., Xu, H-J., Jiang, H., Liu, Y-C., Fu, Y. and Wuc, Y-D. (2009) A study on

the reactions of NADH models with electron-deficient alkenes. A probe for

the extreme of concerted electron-hydrogen atom transfer mechanism.

Tetrahedron Lett., 50: 312-315.

Finberg, R. W., Moellering. R. C., Tally, F. P., Craig, W. A., Pankey, G. A.,

Dellinger, E. P., West, M. A., Joshi, M., Linden, P. K., Rolston, K. V.,

Rotschafer, J. C. and Rybak, M. J. (2004) The Importance of Bactericial

Drugs: Future Directions in Infectious Disease. Clin. Infect. Dis., 39: 1314–

1320.

Fischbach, M. A. and Walsh, C. T. (2009) Antibiotics for emerging pathogens.

Science, 325: 1089-1093.

Fleming, A. (1980) On the Antibacterial Action of Cultures of a Penicillium, with

Special Reference to Their Use in the Isolation of B. influenza. Brit. J. Exp.

Path., 10: 226-236. (Rev. Infect. Dis. 1929, 2: 129-139).

Florey, H. W. (1945) Use of Micro-organisms for Therapeutic Purposes. Br. Med. J.,

2: 635–642.

Fogari, R., Mugellini, A., Zoppi, A., Lazzari, P., Maurizio, D., Renaldi, A. and Preti,

P. (2005) Effect of successful hypertension control by manidipine or lisinopril

on albuminuria and left ventricular mass in diabetic hypertensive patients with

microalbuminuria. Eur. J. Clin. Pharmacol., 61: 483-490.

184

Forrest, R. D. (1982) Early history of wound treatment. J. R. Soc. Med., 75: 198–205.

Foster, W. and Raoult, A. (1974) Early descriptions of antibiosis. J. R. Coll. Gen.

Pract., 24: 889–94.

Frankov, I. A., Kirillov, M. V., Sokolova, T. N., Skupskaya, R., Kharitonovich, A. N.

and Chizhevskaya, I. I. (1985) Synthesis and pharmacological properties of

alkyl derivatives of 3-carboxyalkylrhodanine. Khim.-Farm. Zh., 19: 943-946,

[Chem. Abstr. 1986, 104: 129831].

Free, C. A., Majchrowich, E. and Hess, S.M. (1971) Mechanism of inhibition of

histidine decarboxylase by rhodanines. Biochem. Pharmacol., 20: 1421–1428.

Friebe, W. G., Krell, H. W., Woelle, S. and Wolff, H. P. (2001) Thiazolidine

carboxylic acid derivatives and their use in the treatment of cancer. WO Pat.

0157006.

Fujishima, H. and Tuboto, K. (2002) Improvement of corneal fluorescein staining in

post cataract surgery of diabetic patients by an oral aldose reductase inhibitor,

ONO-2235. Br. J. Ophthalmol., 86: 860–863.

Fujita, T., Sugiyama, Y., Taketomi, S., Sohda, T., Kawamatsu, Y., Iwatsuka, H. and

Suzuoki, Z. (1983) Reduction of insulin resistance in obese and/or diabetic

animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione

(ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes, 32:

804-810.

Fukuzumi, S., Patz, M., Suenobu, T., Ishida, A. and Mikami, K. in Fuller-enes.

Recent Advances in the Chemistry and Physics of Fullerenes and Related

185

Materials Vol. 4 (Eds Kadish, K. M. and Ruoff, R. S.) (Pennington, NJ: The

Electrochemical Society, 1997) p. 45.

Fukuzumi, S., Suenobu, T., Patz, M., Hirasaka, T., Itoh, S., Fujitsuka, M. and Ito, O.

(1998) Selective One-Electron and Two-Electron Reduction of C60 with

NADH and NAD Dimer Analogues via Photoinduced Electron Transfer. J.

Am. Chem. Soc., 120: 8060-8068.

Furdik, M. and Gvozdjakova, A. (1964) Acta Fac. Rerum. Natur. Univ.

Commenianae Chim., 8:581, Chem. Abstr. 1964, 61:13277.

Gadekar, L.S., Arbad, B.R. and Lande, M.K. (2008) Org. Chem. An: Ind. J., 4: 458-

461.

Garden, S. J., Guimaraes, C. R. W., Correa, M. B., Oliveira, C. A. F., Pinto, A. C. and

Alencastro, R. B. (2003) Synthetic and Theoretical Studies on the Reduction

of Electron Withdrawing Group Conjugated Olefins Using the Hantzsch 1,4-

Dihydropyridine Ester. J. Org. Chem., 68: 8815-8822.

Gaspard-Iloughmane, H. and Le Roux, C. (2004) Bismuth(III) Triflate in Organic

Synthesis Eur. J. Org. Chem., 2517–2532.

Gaspard-Iloughmane, H. and Le Roux, C. (2006) Recent advances in the use of

bismuth(III) triflate in organic synthesis Trends Org. Chem., 11: 65-80.

Gaspard-Iloughmane, H. and Le Roux, C. (2008) Bi(III) Lewis acids. In: Acid

catalysis in modern organic chemistry, Yamamoto, H., Ishihara, K., Eds.,

Wiley-VCH, Weinheim, Germany, pp. 551.

Gelbard, G., Lin, J. and Roques, N. (1992) Reductions with NADH Models. 3. The

High Reactivity of Hantzsch Amides. J. Org. Chem., 57: 1789-1793.

186

Gerwick, W. H., Lopez, A., Van Duyne, G. D., Clardy, J., Ortiz, W. and Buez, A.

(1986) Hormothamnione, a novel cytotoxic styrylchromone from the marine

cyanophyte hormothamnion enteromorphoides grunow. Tetrahedron Lett., 27:

1979-1982.

Ghosh, C. K. and Patra, A. (2008) Chemistry and application of 4-oxo-4H-1-

benzopyran-3-carboxaldehyde. J. Het. Chem., 45: 1529-1547.

Giles, R. G., Lewis, N. J., Quick, J. K., Sasse, M. J., Urquhart, M. W. J. and Youssef,

L. (2000) Regiospecific Reduction of 5-Benzylidene-2,4-Thiazolidinediones

and 4-Oxo-2-thiazolidinethiones using Lithium Borohydride in Pyridine and

Tetrahydrofuran. Tetrahedron, 56: 4531-4537.

Goes, A. J. S., DeLima, M. C. A., Galdino, S. L., Pitta, I. R., Luu-Duc, C. (1991)

Synthesis and antifungal activity of chlorobenzyl benzylidene

thiazolidinediones and substituted of imidazolidinediones. Ann. Pharm.

Franc., 49: 92-98.

Goldshleger, N. F., Astakhova, A. S., Lobach, A. S., Boiko, G. N., Denisov, N. N.,

Nadtochenko, V. A., Roshchupkina, O. S. and Shulga, Y. M. (1996) Reaction

of Diethyl 2,6-Dimethyl-1,4-dihydropyridine-3,5-dicarboxylate with Fullerene

C60. Izv. Akad. Nauk, Ser. Khim., 2531-2534.

Goldshleger, N. F., Boiko, G. N., Denisov, N. N., Nadtochenko, V. A., Kaplunov, M.

G. and Kulikov, A. V. in Sb. Dokl. VII Vseros. Konf. Po

Metalloorganicheskoi Khimii, Moskva, 1999 (Abstracts of Reports of the

VIIth All-Russian Conference on Organometallic Chemistry, Moscow, 1999)

Vol. 2: 122.

187

Goswami, P., Ali, S. Khan, M. M. and Das, B. (2008) Metal Free One Pot Approach

Towards the Synthesis of Hantzsch Esters and their Application as the

Hydrogen Source for the Reduction of Activated Olefins Catalysed by Bromo

Dimethyl Sulfonium Bromide (BDMS) Lett. Org. Chem., 5: 659-664.

Grant, E. B., Guiadeen, D., Baum, E. Z., Foleno, B. D., Jin, H., Montenegro, D. A.,

Nelson, E.A., Bush, K. and Hlasta, D. J. (2000) The synthesis and SAR of

rhodanines as novel class C beta-lactamase inhibitors. Bioorg. & Med. Chem.

Lett., 10: 2179–2182.

Guin, J., Frohlich, R. and Studer, A. (2008) Thiol-Catalyzed Stereoselective Transfer

Hydroamination of Olefins with N-Aminated Dihydropyridines. Angew.

Chem. Int. Ed., 47: 779-782.

Guizzetti, S., Benaglia, M. and Rossi, S. (2009) Highly Stereoselective Metal-Free

Catalytic Reduction of Imines: An Easy Entry to Enantiomerically Pure

Amines and Natural and Unnatural r-Amino Esters. Org. Lett., 11: 2928-2931.

Guo, Q-S., Du, D-M. and Xu, J. (2008) The Development of New Double Axially

Chiral Phosphoric Acids and Their Catalytic Asymmetric Transfer

Hydrogenation of Quinolines. Angew. Chem. Int. Ed., 47: 759-763.

Gutierrez, O., Iafe, R. G. and Houk, K. N. (2009) Origin of Stereoselectivity in the

Imidazolidinone-Catalyzed Reductions of Cyclic α,β-Unsaturated Ketones.

Org. Lett., 11: 4298-4301.

Habib, N. S., Ridal, S. M., Badaweyl, E. A. M., Fahmyl, H. T. Y. and Ghozlan, H. A.

(1997) Synthesis and antimicrobial activity of rhodanine derivatives. Eur. J.

Med. Chem., 32:759-762.

188

Han, Z-Y., Xiao, H. and Gong, L-Z. (2009) Dynamic kinetic asymmetric transfer

hydrogenation of racemic 2,4-diaryl-2,3-dihydrobenzo[b][1,4]diazepines

catalyzed by chiral phosphoric Acids. Bioorg. Med. Chem. Lett., 19: 3729-

3732.

Han, Z-Y., Xiao, H., Chen, X-H. and Gong, L-Z. (2009) Consecutive Intramolecular

Hydroamination/Asymmetric Transfer Hydrogenation under Relay Catalysis

of an Achiral Gold Complex/Chiral Brønsted Acid Binary System. J. Am.

Chem. Soc., 131: 9182-9183.

Hangarge, R. V., Jarikote, D. V. and Shingare, M. S. (2002) Knoevenagel

condensation reactions in an ionic liquid Green Chemistry, 4: 266-268.

Hansen, M. M., Harkness, A. R., Khau, V. V., Martinelli, M. J. and Deeter, J. B.

(1996) Tetrahedron: Asymmetry, 7: 2515-2518.

Hantzsch, A. (1881) Condensation produkte aus Aldehy dammoniak and

ketoniartigen Verbindungen. Ber., 14: 1637-1638.

Hantzsch, A. (1882) Ueber die Synthese Pyridinartiger Verbindungen aus

Acetessigather und Aldehydammoniak. Ber., 215: 1-82.

Hardej, D., Ashby Jr., C. R., Khadtare, N. S., Kulkarni, S. S., Singh, S. and Talele, T.

T. (2010) The synthesis of phenylalanine-derived C5-substituted rhodanines

and their activity against selected methicillin-resistant Staphylococcus aureus

(MRSA) strains. Eur. J. Med. Chem., 45: 5827-5832

Harrower, A. D. B. (1994) Comparison of Efficacy, Secondary Failure Rate, and

Complications of Sulfonylureas J. Diab. Compd., 8: 201-203.

189

He, R., Toy, P. H. and Lama, Y. (2008) Polymer-Supported Hantzsch1,4-Dih

ydropyridine Ester: An Efficient Biomimetic Hydrogen Source Adv. Synth.

Catal., 350: 54-60.

Heerding, D. A., Christmann, L. T., Clark, T. J., Holmes, D. J., Rittenhouse, S. F.,

Takata, D. T. and Venslavsky, J. W. (2003) New

benzylidenethiazolidinediones as antibacterial agents. Bioorg. Med. Chem.

Lett., 13: 3771-3773.

Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins,

J. L., Harrington, W. W. Jr., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I.,

Kliewer, S. A., Lake, D. H., Leesnitzer, L. M., Lehmann, J. M., Lenhard, J.

M., Orband-Miller, L. A., Miller, J. F., Mook, R. A. Jr., Noble, S. A., Oliver,

W. Jr., Parks, D. J., Plunket, K. D., Szewczyk, J. R. and Willson, T. M. (1998)

N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 1. Discovery of a Novel

Series of Potent Antihyperglycemic and Antihyperlipidemic Agents. J. Med.

Chem., 41: 5020-5036.

Heravi, M. M., Bakhtiari, K., Javadi, N. M., Bamoharram, F. F., Saeedi, M. and

Oskooie, H. A. (2007) K7[PW11CoO40]-catalyzed one-pot synthesis of

polyhydroquinoline derivatives via the Hantzsch three component

condensation. J. Mol. Cat. A: Chem., 264: 50-52.

Heravi, M. M., Dirkwand, F., Oskooie, H. A. and Ghassemzadeh, M. (2005)

Aromatization of Hantzsch 1,4-dihydropyridines with Dess-Martin

periodinane under classical heating and microwave irradiation in solventless

system, Heterocycl Commun., 11: 75-78.

190

Hoffman, T. J., Dash, J., Rigby, J. H., Arseniyadis, S. and Cossy, J. (2009)

Enantioselective Organocatalytic Conjugate Reduction of β-Azole-Containing

α,β-Unsaturated Aldehydes Org. Lett., 11: 2756-2759.

Hoffmann, S., Nicoletti, M. and List, B. (2006) Catalytic Asymmetric Reductive

Amination of Aldehydes via Dynamic Kinetic Resolution. J. Am. Chem. Soc.,

128: 13074-13075.

Hoffmann, S., Seayad, A. M. and List, B. (2005) A Powerful Brønsted Acid Catalyst

for the Organocatalytic Asymmetric Transfer Hydrogenation of Imines.

Angew. Chem. Int. Ed., 44: 7424-7427.

Hoftiezer, V. and Carpenter, A. M. (1973) Comparison of streptozotocin and alloxan

induced diabetes in rats. Diabetologia., 9: 178-184.

Holman, R. R., Turner, R. C. (1991) Textbook of Diabetes, ed. by Pickup J. C. and

Williams G., Blackwell Scientific Publications, London, pp. 462-476.

Hossain, S. U. and Bhattacharya, S. (2007) Synthesis of O-prenylated and O-

geranylated derivatives of 5-benzylidene2,4-thiazolidinediones and evaluation

of their free radical scavenging activity as well as effect on some phase II

antioxidant/detoxifying enzymes. Bioorg. & Med. Chem., 17: 1149–1154.

http://www.diabetesguidelines.com/helth/health/dwk/pro/guidelines/type1/2_4

.htm. International Diabetes Federation.

http://www.rsc.org/chemistryworld/Issues/2008/March/TheTroubleWithAntibi

otics.asp (accessed February 12, 2010).

Hu, B., Ellingboe, J., Gunawan, I., Han, S., Largis, E., Li, Z., Malamas, M., Mulvey,

R., Oliphant, A., Sum, F. -W., Tillett, J. and Wong, V. (2001) 2,4-

191

Thiazolidinediones as Potent and Selective Human β3 Agonists. Bioorg. &

Med. Chem., 11: 757–760.

Hua, R. (2008) Recent advances in bismuth-catalyzed organic synthesis Curr. Org.

Synth., 5: 1-27.

Hua-Jiana, X., You-Cheng, L. and Yao, F. (2008) Metal-free Uncatalyzed Reduction

of α,β-Unsaturated Ketones Mediated by Hantzsch 1,4-Dihydropyridine Chin.

J. Chem., 26, 599-601.

Huang, Y-B., Yi, W-B. and Cai, C. (2010) An efficient, recoverable fluorous

organocatalyst for direct reductive amination of aldehydes. J. Fluor. Chem.,

131: 879-882.

Huber, J. E. PCT Int. Appl. WO 92-US10329, CAN, 119, 24994.

Hulin, B., Newton, L. S., Lewis, D. M., Genereux, P. E., Gibbs, E. M. and Clark, D.

A. (1996) Hypoglycemic activity of a series of alpha-alkylthio and alpha-

alkoxy carboxylic acids related to ciglitazone. J. Med. Chem., 39: 3897-3907.

Ikeda, H., Shino, A., Matsuo, T., Iwatsuka, H. and Suzuoki, Z. (1981) A new

genetically obese-hyperglycemic rat (Wistar fatty). Diabetes, 30: 1045-1050.

Ila, S., Gregor, E. K., Anderson, K. R., Haleen, S. J., Shih, Y. H., Weishaar, R. E. and

Taylor, M. D. (1991) Calcium channel blocking and positive inotropic

activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-

4-aryl-3-pyridinecarboxylate and analogs. Synthesis and structure-activity

relationships. J. Med. Chem., 34: 2248-2260.

Inamori, Y., Muro, C., Tanaka, R., Adachi, A., Miyamoto, K. and Tsujibo, H. (1992)

Phytogrowthinhibitory activity of sulfur-containing compounds. I. Inhibitory

192

activities of thiazolidine derivatives on plant growth. Chem. Pharm. Bull., 40:

2854–2856.

Infectious disease experts call for 10 new antibiotics by 2020.

http://www.sciencedaily.com/releases/2009/11/091123132633.htm (accessed

February 8, 2010).

Intensive blood-glucose control with sulphonylureas or insulin compared with

conventional treatment and risk of Complications in Patients with Type 2

diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

(1998) The Lancet, 352: 837-853.

International Diabetes Federation (IDF) Diabetes Atlas. 4th. 2009. Brussels,

Belgium, International Diabetes Federation. 2009.

International Diabetes federation and World Dental Federation (WDF). Diabetes and

oral health. http://www.idf.org/diabetes and oral health . 25-10-2007. 8-5-

2011.

International Diabetes Federation: Guidelines to Type 1 Diabetes. (1998)

Irvine, M. W., Patrick, G. L., Kewney, J., Hastings, S. F. and MacKenzie, S. J. (2008)

Rhodanine derivatives as novel inhibitors of PDE4. Bioorg. & Med. Chem.

Lett., 18: 2032–2037.

Isseman, I. and Green, S. (1990) Activation of a member of the steroid hormone

receptor superfamily by peroxisome proliferators. Nature (London), 347: 645-

650.

193

Ito, M., Kondo, Y., Nakatani, A. and Naruse, A. (1999) New model of progressive

Non-Insulin-Dependent Diabetes Mellitus in mice induced by streptozotocin.

Biol. Pharm. Bull., 22: 988-989.

Itoh, T., Nagata, K., Kurihara, A., Miyazaki, M. and Ohsawa, A. (2002) Reductive

amination of aldehydes and ketones by a Hantzsch dihydropyridine using

scandium triflate as a catalyst. Tetrahedron Lett., 43: 3105-3108.

Itoh, T., Nagata, K., Miyazaki, M., Ishikawa, H., Kurihara, A. and Ohsawa, A. (2004)

A selective reductive amination of aldehydes by the use of Hantzsch

dihydropyridines as reductant. Tetrahedron, 60: 6649-6655.

Iwamoto, Y., Akanuma, Y., Kosaka, K., Shigeta, Y., Kazuya, T. and Kaneko, T.

(1996) Effects of troglitazone: a new hypoglycemic agent in patients with

N1DDM poorly controlled by diet therapy. Diabetes Care, 19: 151-156.

Iwatsuka, H., Shino, A. and Suzuoki, Z. (1970) General survey of diabetic features of

yellow KK mice. Endocrinol. Jpn., 17: 23-35.

Jeong, T.-S., Kim, J. -R., Kim, K. S., Cho, K. -H., Bae, K. -H. and Lee, W. S. (2004)

Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on

LDL oxidation. Bioorg. & Med. Chem., 12: 4017–4023.

Ji, S.-J., Jiang, Z.-Q., Lu, J. and Loh, Y.-P. (2004) Facile Ionic Liquids-Promoted

One-Pot Synthesis of Polyhydroquinoline Derivatives under Solvent-Free

Conditions. Synlett., 831-835.

Johansson E. B. and Tjalve, H. (1978) Studies on the tissue-disposition and fate of

streptozotocin with special reference to the pancreatic islets. Acta Endocrinol.,

89: 339-351.

194

Junod, A., Lambert, A. E., Atauffacher, W. and Renold, A. E. (1969) Diabetogenic

action of streptozotocin: Relationship of dose to metabolic response. J Clin

Invest., 48: 2129-2139.

Kamioka, S., Ajami, D. and Rebek Jr., J. (2009) Synthetic autocatalysts show

organocatalysis of other reactions. Chem. Commun., 7324-7326.

Kang, Q., Zhao, Z-A. and You, S-L. (2007) Highly Enantioselective Transfer

Hydrogenation of a-Imino Esters by a Phosphoric Acid. Adv. Synth. Catal.,

349: 1657-1660.

Karale, B. K., Chavan, V. P., Mane, A. S., Hangarge, R. V., Gill, C. H. and Shingare,

M. S. (2002) Microwave Induced Synthesis of 3-Methyl-4-[(chromon-3-

yl)methylene]-1-phenylpyrazolin-5-(4H)-ones with Alumina Support and in

Solvent-Free Conditions. Synth. Commun., 32: 497-502.

Karami, B., Montazerozohori, M. and Nasr-Esfahani, M. (2005) Catalytic

aromatization of Hantzsch 1,4-dihydropyridines by bis(salicylaldehyde-1,2-

phenylenediimine) Mn(III) chloride using urea hydrogen peroxide as mild and

efficient oxidant, Heterocycles, 65: 2181-2188.

Katritzky, A.R. and Pozharskii, A.F. Handbook of Heterocyclic Chemistry, 2nd ed.,

Pergamon: New York, 2000, 392.

Khadikar, B. M., Gaikar, V. G. and Chitnavis, A. A. (1995) Aqueous Hydrotrope

Solution as a Safer Medium for Microwave-Enhanced Hantzsch

Dihydropyridine Ester Synthesis Tetrahedron Lett., 36: 8083-8086.

195

Kim, D. H. (2008) Treatment Outcomes and Long-term Survival in Patients with

Extensively Drug-resistant Tuberculosis. Am. J. Respir. Crit. Care Med., 178:

1075-1082.

Kingston, W. (2008) Irish contributions to the origins of antibiotics. Iri. J.Med. Sci.,

177: 87–92.

Klevens, R. M. (2007) Invasive methicillin-resistant Staphylococcus aureus infections

in the United States. J. Am. Med. Assoc., 298: 1763-1771.

Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U.,

Manglesdorf, D. J., Umesono, K. and Evans, R. M. (1994) Differential

expression and activation of a family of murine peroxisome proliferator-

activated receptors. Proc. Natl. Acad. Sci. U.S.A., 91: 7355-7359.

Komatsu, T., Hirano, T., Songkram, C., Kawachi, E. and Kagechika, H. (2007) Novel

thyroid hormone receptor antagonists with an N-alkylated diphenylamine

skeleton. Bioorg. & Med. Chem., 15: 3115–3126.

Korner, H. (1908) Derivatives of dithicarbaminoacetic acid. Ber. Dtsch. Chem. Ges.,

41: 1901–1905, [Chem. Abstr. 1908, 2, 12300].

Kumar, A., Sharma, S. and Maurya, R. A. (2010) Single nucleotide catalyzed

biomimetic reductive amination. Adv. Synth. Catal., 352: 2227-2230.

Kumar, R. and Chandra, R. in Adv. Heterocycl. Chem., Academic Press, 2001, p. 269.

Kutney, J. P. (1977) Dihydropyridines in biosynthesis and synthesis. Heterocycles, 7:

593-614.

196

Lacova, M., El-Shaaer, H.M., Loos, D., Matulova, M., Chovancova, J. and Furdik, M.

(1998) Evaluation of Effect of Microwave Irradiation on Syntheses and

Reactions of Some New 3-Acyl-methylchromones. Molecules, 3: 120-131.

Lacova, M., Gasparova, R., Loos, D., Liptay, T. and Pronayova N. (2000) Effect of

Microwave Irradiation on the Condensation of 6-Substituted 3-

Formylchromones with Some Five-membered Heterocyclic Compounds.

Molecules, 5: 167-178.

Lacova, M., Loos, D., Furdik, M., Matulova, M. and El-Shaaer, H.M. (1998)

Synthesis and Reactions of New 4-Oxo-4H-benzopyran-3-carboxaldehydes

Containing Hydroxy Groups or 2-Oxopyran Cycles. Molecules, 3: 149-158.

Lacova, M., Puchala, A., Solcanyova, E., Lac, J., Kois, P., Chovancova, J. and

Rasala, D. (2005) 3-Formylchromones IV. The Rearrangement of 3-

Formylchromone Enamines as a Simple, Facile Route to Novel Pyrazolo[3,4-

b]pyridines and the Synthetic Utility of the Latter. Molecules, 10: 809-821.

Landsberg, H. (1949) Prelude to the Discovery of Penicillin. Isis, 40: 225–227.

Lavery, L. A., Wunderlich, R. P. and Tred Well, J. L. (2005) Disease management for

the diabetic foot: effectiveness of a diabetic foot prevention program to reduce

amputations and hospitalizations. Diabetes research and clinical practice.

Diabetes Res. Clin. Pract., 70: 31-37.

Lavilla, R. (2002) Recent developments in the chemistry of dihydropyridines. J.

Chem. Soc., Perkin Trans. 1: 1141-1156.

197

Le Roux, C. and Dubac, J. (2002) Bismuth(III) Chloride and Triflate: Novel Catalysts

for Acylation and Sulfonylation Reactions. Survey and Mechanistic Aspects

Synlett, 2: 181-200.

Lee, H. W., Kim, B. Y., Ahn, J. B., Son, H. J., Lee, J. W., Ahn, S. K. and Hong, C. I.

(2002) Hantzsch Dihydropyridine: An Effective and Convenient

Regioselective Reducing Agent for 5-Benzylidene-2,4-thiazolidinedione

Derivatives. Heterocycles, 57: 2163-2173.

Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M.

and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity

ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

J. Biol. Chem., 270: 12953-12956.

Leonard, N. M., Wieland, L. C. and Mohan, R. S. (2002) Applications of bismuth(III)

compounds in organic synthesis. Tetrahedron, 58: 8373-8397.

Lesyk, R.B. and Zimenkovsky, B.S. (2004) 4-Thiazolidones: Centenarian History,

Current Status and Perspectives for Modern Organic and Medicinal

Chemistry. Curr. Org. Chem., 8: 1547-1577.

Lesyk, R.B., Zimenkovsky, B.S. and Troc’ko, N. (2004) Search of potential aldose

reductase inhibitors among 5-arylidene-4-oxothiazolidine-3-alkanoic acids

derivatives. Ukrainica Bioorganica Acta, 1: 29-38.

Lesyk, R.B., Zimenkovsky, B.S., Troc’ko, N. and Kazmirchuk, G. (2002) Annales

Universitatis Mariae Curie-Sklodowska, 15: 39-45.

Lewis, S. E. (2009) Synthetic methods Part (ii) Oxidation and reduction methods,

Annu. Rep. Prog. Chem., Sect. B, 105: 35-74.

198

Li, G. and Antilla, J. C. (2009) Highly Enantioselective Hydrogenation of Enamides

Catalyzed by Chiral Phosphoric Acids Org. Lett., 11:1075-1078.

Li, H. S. and Li, Y. Q. (2010) Potassium iodide catalyzed reductive dehalogenation of

a-halo-ketones using Hantzsch ester diethyl 1, 4-dihydro-2,6-

dimethylpyridine-3,5-dicarboxylate as reductant Chin. Chem. Lett., 21: 931-

934.

Lian, Y. and Hinkle, R.J. (2006) BiBr3-Initiated Tandem Addition/Silyl-Prins

Reactions to 2,6-Disubstituted Dihydropyrans. J. Org. Chem., 71: 7071-7074.

Libermann, D., Himbert, J. and Hengl, L. (1948) La thiazolidione, point de depart

d'une synthése des acides thiopyruviques et thioglyoxyliques substituées. Bull.

Soc. Chim. France, 4: 1120-1124.

Liebl, A. (2002) Challenges in optimal metabolic control of diabetes. Diabetes

Metab. Res. Rev., 18: 36-41.

Limbird, L. E. (2004) The receptor concept: a continuing evolution. Mol. Interv., 4:

326–336.

Lindblad, W. J. (2008) Review Paper: Considerations for Determining if a Natural

Product Is an Effective Wound-Healing Agent. Inter. J. Low. Ext. Wounds, 7:

75–81.

Liu, J., Wu, F., Chen, L., Hu, J., Zhao, L., Chen, C. and Peng, L. (2011) Evaluation of

dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase

inhibitors Bioorg. & Med. Chem. Lett., 21: 2376–2379.

199

Liu, Q., Li, J., Shen, X-X., Xing, R-G., Yang, J., Liu, Z. and Zhou, B. (2009)

Hydrogenation of olefins using Hantzsch ester catalyzed by palladium on

carbon. Tetrahedron Lett., 50: 1026-1028.

Liu, X.-F., Zheng, C.-J., Sun, L.-P., Liu, X.-K. and Piao, H.-R. (2011) Synthesis of

new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid

moieties as potential anti-bacterial agents. Eur. J. Med. Chem., 46: 3469-3473.

Liu, Z. G., Li, N., Yang, L., Liu, Z. L. and Yu, W. (2007) ZrCl4/Hantzsch 1,4-

dihydropyridine as a new and efficient reagent combination for the direct

reductive amination of aldehydes and ketones with weakly basic amines. Chin.

Chem. Lett., 18: 458-460.

Liu, Z. G., Niu, X. Q., Yu, W., Yang, L. and Liu, Z. L. (2008) Pd/C-catalyzed

selective reduction of aromatic azides with Hantzsch 1,4-dihydropyridine.

Chin. Chem. Lett., 19: 885-888.

Lohray, B. B., Bhushan, V., Rao, B. P., Madhavan, G. R., Murali, N., Rao, K. N.,

Reddy, A. K., Rajesh, B. M., Reddy, P. G., Chakrabarti, R., Vikramadithyan,

R. K., Rajagopalan, R., Mamidi, R. N. V. S., Jajoo, H. K. and Subramaniam,

S. (1998) Novel euglycemic and hypolipidemic agents 1. J. Med. Chem., 41:

1619-1630.

Lohray, B. B., Lohray, V. B., Bajji, A. C., Kalchar, S., Poondra, R. R., Padakanti, S.,

Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Juluri, S., Mamidi, N. V. S.

R. and Rajagopalan, R. (2001) (-) 3-[4-[2-(Phenoxazine-10-yl) ethoxy]

phenyl]-2-ethoxypropanoic Acid [(-) DRF 2725]: A Dual PPAR Agonist with

200

Potent Antihyperglycemic and Lipid Modulating Activity. J. Med. Chem., 44:

2675-2678.

Lounasma, M. and Tolvanen, A. in Comprehensive Heterocyclic Chemistry II, ed.

Katritzky, A. R., Rees, C. W. and Scriven, E. F. V. Pergamon, Oxford, 1996,

p. 135.

Love, B. and Snader, K. M. (1965) The Hantzsch reaction. I. Oxidative dealkylation

of certain dihydropyridines J. Org. Chem., 30: 1914-1916.

Maccari, R., Ciurleo, R., Giglio, M., Cappiello, M., Moschini, R., Corso, A. D.,

Mura, U. and Ottanà, R. (2010) Identification of new non-carboxylic acid

containing inhibitors of aldose reductase. Bioorg. & Med. Chem., 18: 4049–

4055.

Madhavan, G. R., Chakrabarti, R., Reddy, K. A., Rajesh, B. M., Balraju, V., Rao, P.

B., Rajagopalan, R. and Iqbal, J. (2006) Dual PPAR-α and -γ activators

derived from novel benzoxazinone containing thiazolidinediones having

antidiabetic and hypolipidemic potential. Bioorg. & Med. Chem., 14: 584–

591.

Mahalle, R.S., Netankar, P.D., Bondge, S.P. and Mane, R.A. (2008) An efficient

method for Knoevenagel condensation: a facile synthesis of 5-arylidenyl 2,4-

thiazolidinedione. Green Chem. Lett. Rev., 1: 103-106.

Manley, S. (2003) Haemoglobin A1γ-a marker for complications of type 2 diabetes:

the experience from the UK Prospective Diabetes Study (UKPDS). Clin.

Chem. Lab. Med., 41: 1182-1190.

201

Marcelli, T., Hammar, P. and Himo, F. (2008) Phosphoric Acid Catalyzed

Enantioselective Transfer Hydrogenation of Imines: A Density Functional

Theory Study of Reaction Mechanism and the Origins of Enantioselectivity.

Chem. Eur. J., 14: 8562-8571.

Marques-Lopez, E., Herrera, R. P. and Christmann, M. (2010) Asymmetric

organocatalysis in total synthesis – a trial by fire, Nat. Prod. Rep., 27: 1138-

1167.

Marsh, B. and Carbery, D. R. (2008) Synthetic methods Part (ii) Oxidation and

reduction methods, Annu. Rep. Prog. Chem., Sect. B, 104: 35-48.

Martin, N. J. A. and List, B. (2006) Highly Enantioselective Transfer Hydrogenation

of αβ-Unsaturated Ketones. J. Am. Chem. Soc., 128:13368-13369.

Masahiro, K., Wada, Y., Nagai, Y., Nagaoka, A. and Meguro, K. (1989) Synthesis

and biological activities of optical isomers of 2-(4-diphenyl-1-piperizinyl)

ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridedi-

carboxylate (manidipine) dihydrochloride. Chem. Pharm. Bull., 37: 2225-

2228.

Maslov, K. V., Egorov, A. G., Akimova, T. I. and Kaminski, V. A. (2002) Reduction

Conversions of 1,4-Dihydropyridine Derivatives on Interaction of Alicyclic

1,5-Diketones with Nitroanilines. Chem. Heterocycl. Compd., 38: 560-563.

Matano, Y. (2004) Antimony and Bismuth in Organic Synthesis. In: Main Group

Metals in Organic Synthesis, Yamamoto, H., Oshima, K. Eds., Wiley-VCH,

Weinheim, Germany, pp. 753-811.

Mauzerall, D. and Westheimer, F. H. (1955) 1-Benzyldihydronicotinamide-. A model

202

for reduced DPN. J Am. Chem. Soc., 77: 2261-2264. (b)

Mei, L. R., Zhu, X-Q. and Cheng, J-P. (2010) A soluble polymer-supported NADH

model: Synthesis and application. Chinese Sci Bull, 55: 2824-2828.

Menche, D., Bohm, S., Li, J., Rudolph, S. and Zander, W. (2007) Synthesis of

hindered tertiary amines by a mild reductive amination procedure.


Menche, D., Hassfeld, J., Li, J., Menche, G., Ritter, A. and Rudolph, S. (2006)

Hydrogen Bond Catalyzed Direct Reductive Amination of Ketones. Org. Lett.,

8: 741-744.

Meng, Q.-y., Liu, Q., Li, J., Xing, R.-G., Shen, X.-X. and Zhou, B. (2009) First Use

of HEH in Oxazine Synthesis: Hydroxy-Substituted 2H-1,4-Benzoxazine

Derivatives. Synlett, 3283-3286.

Momose, Y., Meguro, K., Ikeda, H,, Hatanaka, C., Oi, S. and Sohda, T. (1991)

Studies on Antidiabetic Agents.X. Synthesis and Biological Activities of.

Pioglitazone and Related Compounds. Chem. Pharm. Bull., 39: 1440-1445.

Moorthy, B. T., Ravi, S., Srivastava, M., Chiruvella, K. K., Hemlal, H., Joy, O. and

Raghavan, S. C. (2010) Novel rhodanine derivatives induce growth inhibition

followed by apoptosis. Bioorg. & Med. Chem. Lett., 20: 6297–6301.

Muathen, H.A. (2003) Selective Nitration of Aromatic Compounds with Bismuth

Subnitrate and Thionyl Chloride. Molecules, 8: 593-598.

Mumm, O. and Diederichsen, J. (1939) Hydrierungen und Dehydrierungen in der

Pyridinreihe, zugleich als Modellversuche für die wasserstoffübertragende

Wirkung der Codehydrasen. Ann. Chem., 538: 195-236.

203

Muro, C., Yasuda, M., Sakagami, Y., Yamada, T., Tsujibo, H., Numata, A. and

Inamori, Y. (1996) Inhibitory activities of rhodanine derivatives on plant

growth. Biocsi. Biotechnol. Biochem., 60: 1368–1371.

Murugana, R., Anbazhagan, S. and Narayanan, S. S. (2009) Synthesis and in vivo

antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition

reactions with thiazolidinedione and rhodanine derivatives Eur. J. Med.

Chem., 44: 3272–3279

Muzart, J. (1985) Is it Really Useful to Employ Ultrasonic Irradiation in the Self-

Condensation of Ketones Catalyzed by Basic Alumina? Synth. Commun., 15:

285-289.

Nagy, M. V., Chan, E. K., Teruya, M., Forrest, L. E., Likhite, V. and Charles, M. A.

(1989) Macrophage, mediated islet cell cytotoxicity in BB rats. Diabetes, 38:

1329-1331.

Nakayama, H. and Kasoaka, Y. (1996) Chemical identification of binding sites for

calcium channel antagonists Heterocycles, 42: 901-909.

Narcross, B. E., Klinedinst, P. E. and Westheimer, F. H. (1962) The Reduction of

Olefinic Double Bonds with Dihydropyridines. J Am. Chem. Soc., 84: 797-

802.

Nathan, C. (2004) Antibiotics at the crossroads. Nature, 431: 899-902.

Nathan, C. and Goldberg, F. M. (2005) Outlook: the profit problem in antibiotic

R&D. Nat. Rev. Drug Discov., 4: 887-891.

204

Nguyen, Q. P. B. and Kim, T. H. (2011) S-Benzyl Isothiouronium Chloride as a

Recoverable Organocatalyst for the Direct Reductive Amination of

Aldehydes. Tetrahedron Lett., 52: 5004-5007.

Nguyen, T. B., Bousserouel, H., Wang, Q. and Gueritte, F. (2010) Chiral Phosphoric

Acid-Catalyzed Enantioselective Transfer Hydrogenation of ortho-

Hydroxyaryl Alkyl N-H Ketimines. Org. Lett., 12: 4705-4707.

Nguyen, T. B., Bousserouel, H., Wang, Q. and Guéritte, F. (2011) Phosphoric Acid

Catalyzed Enantioselective Transfer Hydrogenation of N-Aryl ortho-

Hydroxybenzophenone Ketimines. Adv. Synth. Catal., 353: 257-261.

Niknam, K., Zolfigol, M. A., Razavian, S. M. and Baltork, I. M. (2005)

Molybdatophosphoric Acid/NaNO2/Wet SiO2 as an Efficient System for

Oxidation of 1,4-Dihydropyridines under Mild and Heterogeneous Conditions

Heterocycles, 65: 657-660.

Niu, X. Q., Liu, Z. G., Yu, W. and Wu, L. M. (2009) Chin. J. Org. Chem., 29: 229-

233.

Nohara, A., Ishiguro, T. and Sanno, Y. (1974) A novel conversion reaction of 4-oxo-

4H-1-benzopyran-3-carboxaldehydes to 3-substituted-5-(2-hydroxybenzoyl)-

2(1H)-pyridones. Tetrahedron Lett., 15: 1183-1186.

Nohara, A., Umetani, T. and Sanno, Y. (1974) Studies on antianaphylactic agents—I :

A facile synthesis of 4-oxo-4H-1-benzopyran-3-carboxaldehydes by Vilsmeier

reagents. Tetrahedron, 30: 3553-3561.

Nomura, M., Kinoshita, S., Satoh, H., Maeda, T., Murakami, K., Tsunoda, M.,

Miyachi, H. and Awano, K. (1999) (3-Substituted Benzyl)thiazolidine-2,4-

205

diones as Structurally New Antihyperglycemic Agents. Bioorg. & Med. Chem.

Lett., 9: 533-538.

Norcross, B. E., Klinedinst Jr., P. E. and Westheimer, F. H. (1962) The Reduction of

Olefinic Double Bonds with Dihydropyridines. J. Am. Chem. Soc., 84: 797-

802.

Nugenta, T. C. and El-Shazlya, M. (2010) Chiral Amine Synthesis – Recent

Developments and Trends for Enamide Reduction, Reductive Amination, and

Imine Reduction, Adv. Synth. Catal., 352: 753-819.

Nussbaum, F. V., Brands, M., Hinzen, B., Weigand, S. and Habich, D. (2006)

Antibacterial natural products in medicinal chemistry - exodus or revial?

Angew. Chem. Int. Ed., 45: 5072-5129.

O'Fallon, E., Pop-Vicas, A. and D'Agata, E. J. (2009) The emerging threat of

multidrug-resistant gram-negative organisms in long-term care facilties.

Gerontol. A Biol. Sci. Med. Sci., 64A: 138-141.

Oguchi, M., Wada, K., Honma, H., Tanaka, A., Kaneko, T., Sakakibara, S., Ohsumi,

J., Serizawa, N., Fujiwara, T., Horikoshi, H. and Fujita, T. (2000) Molecular

Design, Synthesis, and Hypoglycemic Activity of a Series of Thiazolidine-2,4-

diones. J. Med. Chem., 43: 3052-3066.

Ohberg, L. and Westman, J. (2001) An Efficient and Fast Procedure for the Hantzsch

Dihydropyridine Synthesis under Microwave Conditions Synlett., 1296-1298.

Ohika, S., Nishiyama, T., Tatematsu, S., Miyashita, K., Iwata, C. and Imanishi, T.

(1991) Studies on Novel and Chiral 1,4-Dihydropyridines. III.1 Asymmetric

206

Reduction of Some Ketones with Novel NADH Model Compounds, (SS)-3-α-

Tolylsulfinyl)-1,4-dihydropyridines. Tetrahedron, 53: 593-602.

Ohno, A., Yamamoto, H. and Oka, S. (1979) Reduction by a model of NAD(P)H.

XXVI. reduction of C=C bond in 1,3,5-trinitrobenzene. Tetrahedron Lett., 20:

4061-4064.

Ollevier, T. and Mwene-Mbeja, T. M. (2006) Microwave-enhanced bismuth triflate-

catalyzed epoxide opening with aliphatic amines. Tetrahedron Lett., 47: 4051-

4055.

Ono, F., Negoro, R. and Sato, T. (2001) Lithium bromide, a novel and highly

effective catalyst for monothioacetalization of acetals under mild reaction

conditions. Synlett, 1581-1583.

Ono, H. and Kimura, M. (1981) Effect of Ca2+-antagonistic vasodilators, diltiazem,

nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.

Arzneim-Forsch. Drug Res., 31: 1131-1134.

Opperman, T. J., Kwasny, S. M., Williams, J. D., Khan, A. R., Peet, N. P., Moir, D.

T. and Bowlin, T. L. (2009) Aryl Rhodanines Specifically Inhibit

Staphylococcal and Enterococcal Biofilm Formation Antimicrob. Agents

Chemother., 4357–4367.

Orchard, M. G. (2003) Preparation of 5-benzylidene-4-thiazolidinone-2-thione

antifungal agents. WO Pat. 03070238.

Orchard, M. G. and Neuss, J. D. (2002) Preparation of thiazolidines as antifungal

agents. WO Pat. 0222612.

207

Orchard, M. G., Neuss, J. C. and Galley, C. M. S. (2002) Benzylidene

thiazolidinediones and their use as antimycotic agents. WO Pat. 02017915.

Orchard, M. G., Neuss, J. C., Galley, C. M. S., Carr, A., Porter, D. W., Smith, P.,

Scopes, D. I. C., Haydon, D., Vousden, K., Stubberfield, C. R., Young, K. and

Page, M. (2004) Rhodanine-3-acetic acid derivatives as inhibitors of fungal

protein mannosyl transferase 1 (PMT1). Bioorg. & Med. Chem. Lett., 14:

3975–3978.

Ottana, R., Maccari, R., Giglio, M., Corso, A. D., Cappiello, M., Mura, U., Cosconati,

S., Marinelli, L., Novellino, E., Sartini, S., Motta, C. L. and Settimo, F. D.

(2011) Identification of 5-arylidene-4-thiazolidinone derivatives endowed

with dual activity as aldose reductase inhibitors and antioxidant agents for the

treatment of diabetic complications. Eur. J. Med. Chem., 46: 2797-2806.

Ouellet, S. G., Tuttle, J. B. and MacMillan, D. W. C. (2005) Enantioselective

Organocatalytic Hydride Reduction. J. Am. Chem. Soc., 127: 32-33.

Outterson, K. (2007) Will longer antimicrobial patents improve public health?.

Lancet Inf. Dis., 7: 559-566.

Owusu-Ansah, E., Durow, A. C., Harding, J. R., Jordan, A. C., O’Connella, S. J. and

Willis, C. L. (2011) Synthesis of dysideaproline E using organocatalysis. Org.

Biomol. Chem., 9: 265-272.

Pac, C., Ihama, M., Yasuda, M., Miyauchi, Y. and Sakurai, H. (1981) Ru( bpy)32+-

MediatedP hotoreduction of Olefins with l-Benzyl-1,4-dihydronicotinamide:

A Mechanistic Probe for Electron-Transfer Reactions of NAD(P)H-Model

Compounds. J. Am. Chem. Soc., 103: 6495-6497.

208

Palmisano, G., Tibiletti, F., Penoni, A., Colombo, F., Tollari, S., Garella, D.,

Tagliapietra, S. and Cravotto, G. (2011) Ultrasound-enhanced one-pot

synthesis of 3-(Het)arylmethyl-4-hydroxycoumarins in water. Ultrason.

Sonochem., 18: 652-660.

Patil, V., Tilekar, A., Munj, S. M., Mohan, R. and Ramaa, C. S. (2010) Synthesis and

primary cytotoxicity evaluation of new 5-benzylidene-2, 4-thiazolidinedione

derivatives. Eur. J. Med. Chem., 45: 4539-4544.

Pattan, S. R. and Parate, A. N. (2003) Synthesis and evaluation of some 1,4 –

dihydropyridine of biological interest. Indian J. Heterocycl. Chem., 12: 387-

388.

Pelletier, G., Bechara, W. S. and Charette, A. B. (2010) Controlled and

Chemoselective Reduction of Secondary Amides J. Am. Chem. Soc., 132:

12817-12819.

Peuler, J. D., Phare, S. M., Lannussi, A. R. and Hoderek, M. J. (1996) Differential

inhibitory effects of antidiabetic drugs on arterial smooth muscle cell

proliferation. Am. J. Hypertens., 9: 188-192.

Phillips, A. P. (1949) Hantzsch's Pyridine Synthesis. J. Am. Chem. Soc., 71: 4003-

4007.

Pitkanen, O., Martin, J., Hallman, M. and Akerblom, H. (1992) Free radical activity

during development of insulin-dependent diabetes mellitus in the rat. Life Sci.,

50: 335-339.

Polyakov, V. K. and Shevtsova, R. G. (1981) Ukr. Khim. Zh. (Russ. Ed.)., 47: 85-91.

209

Poortvliet, M. C., Schrijvers, C. T. M. and Baan, C. A. (2007) Diabetes : Size, risk

factors and, now and in the future. National Institute for Health and

Environment.

Popov-Pergal, K., Chekovich, Zh. and Pergal, M. (1994) Zhur. Obshch. Khim., 61:

2112-2116.

Postel, M. and Dunach, E. (1996) Bismuth Derivatives for the Oxidation of Organic-

Compounds. Coord. Chem. Rev., 155: 127-131.

Postel, M. and Dunãch, E. (1996) Bismuth derivatives for the oxidation of organic

compounds Coord. Chem. Rev., 155: 127-144.

Prajapati, D., Mahajan, A. R. and Sandhu, J. S. (1992) Studies on chromone

derivatives. A direct and efficient one-pot synthesis of 4-chromone-linked 3-

(N-acylamino)azetidin-2-ones from imines and N-acylalanine . J. Chem. Soc.,

Perkin Trans 1.,1821-1824.

Procuranti, B. and Connon, S. J. (2007) A reductase-mimicking thiourea

organocatalyst incorporating a covalently bound NADH analogue: efficient

1,2-diketone reduction with in situ prosthetic group generation and recycling.

Chem. Commun., 1421-1423.

Projan, S. J. and Bradford, P. A. (2007) Late stage antibacterial drugs in the clinical

pipeline. Curr. Opin. Microbiol., 10: 441-446.

Prousek, J. (1993) Synthesis of 5-Arylidene-2,4,6(1H,3H,5H)pyrimidinetrione

Derivatives. Collect. Czech. Chem. Commun., 58: 3014-3016. Chem. Abstract

1994, 120, 217542j

210

Pushin, A. N., Trachentro, S. E. and Martynov, I. V. (1988) Dokl. Akad. Nauk SSSR,

299: 154-158.

Qin, H., Yamagiwa, N., Matsunaga, S. and Shibasaki, M. (2006) Bismuth-Catalyzed

Intermolecular Hydroamination of 1,3-Dienes with Carbamates,

Sulfonamides, and Carboxamides. J. Am. Chem. Soc., 128: 1611-1614.

Rajamaki, S., Innitzer, A., Falciani, C., Tintori, C., Christ, F., Witvrouw, M.,

Debyser, Z., Massa, S. and Botta, M. (2009) Exploration of novel

thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase

inhibitors Bioorg. & Med. Chem. Lett., 19: 3615–3618.

Rakowitz, D., Maccari, R., Ottana, R. and Vigorita, M. G. (2006) In vitro aldose

reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones. Bioorg. &

Med. Chem., 14: 567–574.

Ramachary, D. B. and Kishor, M. (2008) Direct amino acid-catalyzed cascade

biomimetic reductive alkylations: application to the asymmetric synthesis of

Hajos–Parrish ketone analogues. Org. Biomol. Chem., 6: 4176-4187.

Ramachary, D. B. and Kishor, M. (2010) Direct catalytic asymmetric synthesis of

highly functionalized tetronic acids/tetrahydro-isobenzofuran-1,5-diones via

combination of cascade three-component reductive alkylations and Michael-

aldol reactions. Org. Biomol. Chem., 8: 2859-2867.

Ramachary, D. B. and Prasad, M. S. (2010) Direct Amino Acid-Catalyzed Cascade

Reductive Alkylation of Arylacetonitriles: High-Yielding Synthesis of

Ibuprofen Analogues. Tetrahedron Lett., 51: 5246-5251.

211

Ramachary, D. B., Kishor, M. and Reddy, G. B. (2006) Development of drug

intermediates by using direct organocatalytic multi-component reactions. Org.

Biomol. Chem., 4: 1641-1646.

Rami, H. K. and Smith, S. A. (2000) Synthetic ligands for PPARγ - review of patent

literature 1994-1999. Exp. Opin. Ther. Patents, 10: 623-634.

Ramirez, M.A. and Borja, N.L. (2008) Epalrestat: An aldose reductase inhibitor for

the treatment of diabetic neuropathy. Pharmacotherapy, 28: 646–655.

Ravi, S., Chiruvella, K. K., Rajesh, K., Prabhu, V. and Raghavan, S. C. (2010) 5-

Isopropylidene-3-ethyl rhodanine induce growth inhibition followed by

apoptosis in leukemia cells Eur. J. Med. Chem., 45: 2748-2752

Reddy, C. S. and Raghu, M. (2008) Cerium(IV) Ammonium Nitrate Catalyzed Facile

and Efficient Synthesis of Polyhydroquinoline Derivatives Through Hantzsch

Multicomponent Condensation. Chinese Chem. Lett., 19: 775-779.

Reginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H. and

Lazar, M. A. (1998) A Potent Antidiabetic Thiazolidinedione with Unique

Peroxisome Proliferator-activated Receptor γ-activating Properties J. Biol.

Chem., 273: 32679-32684.

Reginato, M. J., Lazar, M. A. (1999) Mechanisms by which thiazolidinediones

enhance insulin action. Trends Endocrinol Metab., 10: 9-13.

Reglinski, J. (1998) In Chemistry of Arsenic, Antimony and Bismuth, Norman, N.C.,

Ed., Blackie Academic and Professional: New York, pp 403–440.

212

Robbins, M. J., Sharp, R. A., Slonim, A. E. and Burr, I. M. (1980) Protection against

streptozotocin-induced diabetes by superoxide dismutase. Diabetologia., 18:

55-58.

Ronald, H., Boecker, F. and Peter, G. (1986) Oxidation of 4-aryl- and 4-alkyl-

substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by

human liver microsomes and immunochemical evidence for the involvement

of a form of cytochrome P-450. J. Med. Chem., 29:1596-1603.

Rueping, M. and Antonchick, A. P. (2007) Organocatalytic Enantioselective

Reduction of Pyridines. Angew. Chem. Int. Ed., 46: 4562-4565.

Rueping, M., Brinkmann, C., Antonchick, A. P. and Atodiresei, I. (2010) Asymmetric

Synthesis of Indolines by Catalytic Enantioselective Reduction of 3H-Indoles.

Org. Lett., 12: 4604-4607.

Rueping, M., Dufour, J. and Schoepke, F. R. (2011) Advances in catalytic metal-free

reductions: from bio-inspired concepts to applications in the organocatalytic

synthesis of pharmaceuticals and natural products, Green Chem. 13: 1084-

1105

Rueping, M., Merino, E. and Koenigs, R. M. (2010) First Highly Enantioselective

Synthesis of Benzodiazepinones by Catalytic Hydrogenation. Adv. Synth.

Catal., 352: 2629-2632.

Rueping, M., Sugiono, E., Azap, C., Theissmann, T. and Bolte, M. (2005)

Enantioselective Brønsted Acid Catalyzed Transfer Hydrogenation:

Organocatalytic Reduction of Imines. Org. Lett., 7: 3781-3783.

213

Rueping, M., Sugiono, E., Steck, A. and Theissmann, T. (2010) Synthesis and

Application of Polymer-Supported Chiral Brønsted Acid Organocatalysts.

Adv. Synth. Catal., 352: 281-287.

Rueping, M., Tato, F. and Schoepke, F. R. (2010) The First General, Efficient and

Highly Enantioselective Reduction of Quinoxalines and Quinoxalinones.

Chem. Eur. J., 16: 2688-2691.

Rueping, M., Theissmann, T. and Antonchick, A. P. (2006) Metal-Free Brønsted

Acid Catalyzed Transfer Hydrogenation – New Organocatalytic Reduction of

Quinolines. Synlett, 1071-1074.

Ruppert, R., Jeandon, C., Sgambati, A. and Callot, H. J. (1999) Reduction of N-

arylporphyrins to N-arylphlorins: opposite stereochemical courses as a

function of the reducing agent. Chem. Commun., 2123-2124.

Sabitha, G. (1996) 3-Formylchromone as a versatile synthon in heterocyclic

chemistry. Aldrichimica Acta, 29: 15-25.

Sabitha, G. and Kumar Reddy, G. S. K. (2003) Zr(NO3)4: A Versatile oxidizing agent

for aromatization of hantzsch 1,4-dihydropyridinesand 1,3,5-trisubstituted

pyrazolines Synthesis, 1267-1271.

Sachan, N., Kadam, S.S. and Kulkarni, V.M. (2007) Synthesis, antihyperglycemic

activity and QSAR of 5-benzylidene-2,4-thiazolidinediones. Ind. J. Hetro.

Chem., 17: 57-62.

Sadanandam, Y. S., Shetty, M. M., Reddy, K. R. M. and Leelavathi, P. (1994)

Synthesis and Pharmacology of New 1,4-Dihydropyridines. 2,6-Dimethyl-4-

(substituted phenyl) or (2-furyl)-, (2-thienyl)- or (3-pyridyl)-3,5-di( (N-

214

methyl) or (N-diethyl))carbamoyl-1,4-dihydropyridines as Potent Calcium-

Channel Blockers. Eur. J. Med. Chem., 29: 975-979.

Sadashiva, M. P., Mallesha, H., Hitesh, N. A. and Rangappa, K. S. (2004) Synthesis

and microbial inhibition study of novel 5-imidazolyl substituted

isoxazolidines. Bioorg. Med. Chem., 12: 6389-6395.

Saini, A., Kumar, S. and Sandhu, J. S. (2006) A New LiBr-Catalyzed, Facile and

Efficient Method for the Synthesis of 14-Alkyl or Aryl-14H-

dibenzo[a,j]xanthenes and Tetrahydrobenzo[b]pyrans under Solvent-Free

Conventional and Microwave Heating. Synlett, 12: 1928-1932.

Saini, A., Kumar, S. and Sandhu, J. S. (2007) New Strategy for the Oxidation of

Hantzsch 1,4-Dihydropyridines and Dihydropyrido[2,3-d]pyrimidines

Catalyzed by DMSO under Aerobic Conditions. Synth. Commun., 37: 2317-

2324.

Saini, A., Kumar, S. and Sandhu, J. S. (2008) Hantzsch reaction: Recent advances in

Hantzsch 1,4-dihydropyridines. J. Sci. lnd. Res., 67: 95-111.

Salvador, J. A. R., Pinto, R. M. A. and Silvestre, S.M. (2009) Recent Advances of

Bismuth(III) Salts in Organic Chemistry: application to the Synthesis of

Aliphatics, Alicyclics, Aromatics, Amino Acids and Peptides, Terpenes and

Steroids of Pharmaceutical Interest. Mini-Rev. Org. Chem., 6: 241–274.

Salvador, J. A. R., Pinto, R. M. A. and Silvestre, S.M. (2009) Recent Advances of

Bismuth(III) Salts in Organic Chemistry: Application to the Synthesis of

Heterocycles of Pharmaceutical Interest. Current Organic Synthesis, 6: 426-

470.

215

Sausins, A. and Duburs, G. (1988) Reactions of 1,4- dihydropyridines. Heterocycles,

27: 291-314.

Sawdey, G. W., Ruoff, M. K. and Vittum, P. W. (1950) The Formation of

Azomethine Dyes from 4-Anisylidene- and 4,4'-Anisylidene-bis-pyrazolones.

J. Am. Chem. Soc., 72: 4947-4949.

Schellhase, K. G., Koepsell, T. D., Weiss, N. S., Wagner, E. H. and Reiber, G. E.

(2003) Glucose screening and the risk of complications in Type 2 diabetes

mellitus. J. Clin. Epidemiol., 56: 75-80.

Schmidt, A., Endo, N., Rutledge, S. J., Vogel, R., Shinar, D. and Rodan, G. A. (1992)

Identification of a new member of the steroid hormone receptor superfamily

that is activated by a peroxisome proliferator and fatty acids. Mol.

Endocrinol., 6: 1634-1641.

Schneider, J. F., Lauber, M. B., Muhr, V., Kratzer, D. and Paradies, J. (2011) Readily

available hydrogen bond catalysts for the asymmetric transfer hydrogenation

of nitroolefins. Org. Biomol. Chem., 9: 4323-4325.

Schramm, M., Thomas, G. and Franckowiak, G. (1983) Novel dihydropyridines with

positive inotropic action through activation of Ca2+ channels. Nature, 303:

535-537.

Seeback, D., Thaler, A., Blaser, D. and Ko, S. Y. (1991) Transesterifications with

1,8-Diazabicyclo(5.4.0)undec-7-ene/Lithium Bromide (DBU/LiBr). Also

Applicable to Cleavage of Peptides from Resins in Merrifield Syntheses. Helv.

Chem. Acta, 74: 1102- 1118.

216

Seno, K., Okuna, N., Hishi, K., Murakami, Y., Watanable, F., Matsuura, T., Wada,

M., Yamada, M., Ogawa, T., Okada, T., Hashi Zume, H., Kiim Hara, S. and

Hagishita, J. (2000) Med. Chem., 43: 1041-1044.

Shafiee, A., Rastakari, N. and Zadeh, M. S. (2004) Anticonvusant activity of new 1,4-

dihydropyridine derivatives containing 4-nitroimidazolyl substituents. DARU,

12: 81-87.

Shan, R., Velazqutz, C. and Knaus, E. E. (2004) Syntheses, calcium channel agonist-

antagonist modulation activities, and nitric oxide release studies of

nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-

yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers. J. Med.

Chem., 47: 254-261.

Shen, X-X., Liu, Q., Xing, R-G. and Zhou, B. (2008) Reduction of N-

(alkoxy(aryl)methyl)benzamide Compounds by a Hantzsch Ester 1,4-

Dihydropyridine Using Pd/C as a Catalyst Catal. Lett., 126: 361-366.

Shingare, M. S., Karale, B. K., Gill, C. H., Ganage, K. N. and Bachute, M. T. (1999)

Ind. J. Heterocyclic Chem., 9: 153-156

Shinkai, H., Onogi, S., Tanaka, M., Shibata, T., Iwao, M., Wakitani, K. and Uchida, I.

(1998) Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as

hypoglycemic agents. J. Med. Chem., 41: 1927-1933.

Shinkai, S. and Bruice, T. (1972) Reduction of pyridoxal phosphate (and analogs by

1,4-dihydropyridine. J Am. Chem. Soc., 94: 8258-8258.

217

Shinkaif, S. and Bruice, T. C. (1973) Model Reactions Which Establish a Facile

Reduction of Pyridoxal Phosphate and Analogs by 1,4-Dihydropyridines.

Biochemistry, 12: 1750-1759.

Shukla, S. K., Singh, S. P., Awasthi, L. P. and Mukherjee, D. D. (1982) Indian J.

Pharm. Sci., 44: 153-158, Chem. Abtstr., 1983, 99, 22365u.

Sigma-Aldrich Chemical Co. Catalog, 2009-10.

Sigma-Aldrich online MSDS, http://www.sigmaaldrich.com/

Sim, M. M., Ng, S. B., Buss, A. D., Crasta, S. C., Goh, K. L. and Lee, S. K. (2002)

Benzylidene Rhodanines as Novel Inhibitors of UDP-N-Acetylmuramate/L-

Alanine Ligase. Biorg. Med. Chem. Lett., 12: 697-699.

Simon, L. and Goodman, J. M. (2008) Theoretical Study of the Mechanism of

Hantzsch Ester Hydrogenation of Imines Catalyzed by Chiral BINOL-

Phosphoric Acids. J. Am. Chem. Soc., 130: 8741-8747.

Sing, W. T., Lee, C. L., Yeo, S. L., Lim, S. P. and Sim M. M. (2001) Arylalkylidene

Rhodanine with Bulky and Hydrophobic Functional Group as Selective HCV

NS3 Protease Inhibitor. Bioorg. & Med. Chem. Lett., 11: 91-94.

Singh, B. and Lesher, G. Y. (1980) Reinvestigation of the reaction of ethyl 4,4,4-

trifluoroacetoacetate with aldehydes and ammonia J. Heterocyclic Chem., 17:

1109-1110.

Singh, J., Nathan, C. F., Bryk, R., Samy, R., Pupek, K. and Gurney, M. (2008) Cyclic

carboxylic acid rhodanine derivatives for the treatment and prevention of

tuberculosis. WO Pat. 2008005651.

218

Singh, R., Ramesh, U. V., Goff, D., Laidig, G., Issakani, S. D., Huang, J., Payan, D.

G. and Clough, J. (2004) Rhodanine derivatives and pharmaceutical

compositions containing them. WO Pat. 2004043955.

Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P. and Gale, E. A.

(2009) Intensive Glycemic Control and the Prevention of Cardiovascular

Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials:

A Position Statement of the American Diabetes Association and a Scientific

Statement of the American College of Cardiology Foundation and the

American Heart Association. J. Amer. Coll. Cardio., 53: 298-304.

Smith, T. J., Young, B. L., Denton, H., Hughes, D. L. and Wagner, G. W. (2009) First

small molecular inhibitors of T. brucei dolicholphosphate mannose synthase

(DPMS), a validated drug target in African sleeping sickness Bioorg. & Med.

Chem. Lett., 19: 1749–1752.

Sohda, T., Mizumo, K., Imamiya, E., Tawada, H., Meguro, K. and Kawamastu, Y. Y.

(1982) Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as

potent aldose reductase inhibitors. Chem. Pharm. Bull., 30: 3601-3616.

Sohda, T., Mizuno, K., Imamiya, E., Sugiyama, Y., Fujita, T. and Kawamatsu, Y.

(1982) Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-

methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its

derivatives . Chem Chem. Pharm. Bull., 30: 3580-3600.

Sohda, T., Mizuno, K., Momose, Y., Ikeda, H., Fujita, T. and Meguro, K. (1992)

Studies on Antidiabetic Agents. Part 11. Novel Thiazolidinedione Derivatives

219

as Potent Hypoglycemic and Hypolipidemic Agents. J. Med. Chem., 35: 2617-

2626.

Sohda, T., Momose, Y., Meguro, K., Kawamatsu, Y., Sugiyama, Y. and Ikeda, H.

(1990) Studies on antidiabetic agents. Synthesis and hypoglycemic activity of

5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones. Arzneim.-Forsch., 40: 37-

42.

Sortino, M., Delgado, P., Juarez, S., Quiroga, J., Abonia, R., Insuasty, B., Nogueras,

M., Rodero, L., Garibotto, F. M., Enriz, R. D. and Zacchino, S. A. (2007)

Synthesis and antifungal activity of (Z)-5- aryldenerhodanines. Bioorg. Med.

Chem., 15: 484-494.

Sridhar, R. and Perumal, P. T. (2005) A new protocol to synthesize 1,4-

dihydropyridines by using 3,4,5- trifluoroenzeneboronic acid as a catalyst in

ionic liquid: synthesis of novel 4-(3-carboxyl- 1H-pyrazol-4-yl)-1,4-

dihydropyridines. Tetrahedron, 61: 2465-2470.

Stout, D. M. and Meyers, A. I. (1982) Recent Advances in the Chemistry of

Dihydropyridines. Chem. Rev., 82: 223-243.

Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E. and Cull, C.

A. (2000) Association of glycaemia with macrovascular and microvascular

complications of type 2 diabetes (UKPDS 35): prospective observational

study. B. M. J., 321: 405-412.

Strumvoll, M. and Haring, H.U. (2002) Glitazones: clinical effects and molecular

mechanisms. Ann. Med., 34:217-224.

220

Stumvoll, M., Goldstein, B. J. and Van Haeften, T. W. (2005) Type 2 diabetes:

principles of pathogenesis and therapy. The Lancet, 365: 1333-1346.

Sunkel, C. E., de Casa Juana, M. F., Santos, L., Gomez, M. M., Villaroya, M.,

Morales, A. G., Preigo, J. G. and Ortega, M. P. (1990) 4-Alkyl-1,4-

dihydropyridine derivatives as specific PAF-acether antagonists. J. Med.

Chem., 33: 3205-3210.

Suresh, Kumar, D. and Sandhu, J. S. (2010) Bismuth(III) Chloride–Mediated,

Efficient, Solvent-Free, MWI-Enhanced Doebner Condensation for the

Synthesis of (E)-Cinnamic Acids Synthetic communication, 40: 1915-1919.

Suzuki, H., Ikegami, T. and Matanao, Y. (1997) Bismuth in Organic Transformations

Synthesis, 249-267.

Sykes, R. (2001) Penicillin: from discovery to product. Bull. World Health Organ.,

79: 778–779.

Tanaouchi, T., Kawamura, M., Ajima, A., Mohri, T., Hayashi, M., Terashima, H.,

Hirata, F. and Morimura, T. (1982) Rhodanine derivatives, process for their

preparation, and aldose reductase inhibitor containing the rhodanine

derivatives as active ingredient. EP Pat. 0047109.

Tanaouchi, T., Kawamura, M., Ajima, A., Mohri, T., Hayashi, M., Terashima, H.,

Hirata, F. and Morimura, T. (1984) Rhodanine derivatives, process for their

preparation, and aldose reductase inhibitor containing the rhodanine

derivatives as active ingredient. US Pat. 4464382.

Taniyama, H., Yasui, B., Takehara, N. and Uchida, H. (1959) Chemotherapeutics for

Mycobacterium tuberculosis. XIX. Synthesis and antibacterial activity of

221

some 3-substituted rhodanines. Yakugaku Zasshi, 79, 1465–1468, [Chem.

Abstr. 1960, 54: 34220].

The Diabetes Control and Complications Trials (DCCT), (1993) N. Engl. J. Med.,

329: 683-689.

Theuretzbacher, U. (2009) Future antibiotics scenarios: is the tide starting to turn? Int.

J. Antimicrob. Agents, 34: 15-20.

Tomasic, T. and Masic, L. P. (2009) Rhodanine as a privileged scaffold in drug

discovery. Curr. Med. Chem., 16: 1596-1629.

Tomasic, T., Zidar, N., Premru, M. M., Kikelj, D. and Masic, L. P. (2010) Synthesis

and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-

4,6-pyrimidinediones Eur. J. Med. Chem., 45: 1667–1672.

Torchy, S., Cordonnier, G., Barbry, D. and Eynde, J. J. V. (2002) Hydrogen Transfer

from Hantzsch 1,4-Dihydropyridines to Carbon-Carbon Double Bonds under

Microwave Irradiation. Molecules, 7: 528-533.

Treibs, A., William, R. and Dieter, L. (1981) Ann. Chem., 3: 306-311.

Trinder, P. (1969) Determination of Glucose in Blood Using Glucose Oxidase with

an. Alternative Oxygen Acceptor, Ann. Clin. Biochem., 6: 24-25.

Tripathi, R. P., Verma, S. S., Pandey, J. and Tiwari, V. K. (2008) Recent

Development on Catalytic Reductive Amination and Applications, Curr. Org.

Chem., 12: 1093-1115.

Tsogoeva, S. B. (2010) When chiral product and catalyst are the same: discovery of

asymmetric organoautocatalysis, Chem. Commun., 46: 7662-7669.

Tusell, J. M., Barron, S. and Serratosa, I. (1993) Anticonvulsant activity of ´-HCH,

222

calcium channel blockers and calmodulin antagonists in seizures induced by

lindane and other convulsant drugs Brain Res., 622: 99-104.

Tuttle, J. B., Ouellet, S. G. and MacMillan, D. W. C. (2006) Organocatalytic Transfer

Hydrogenation of Cyclic Enones. J. Am. Chem. Soc., 128:12662-12663.

U.K. Prospective Diabetes Study Group (1995) Diabetes, 44: 1249-1258.

UKPDS. Tight blood pressure control and risk of macro vascular and micro vascular

Complications in Type 2 diabetes: UKPDS 38. UK Prospective Diabetes

Study Group. (1998) B. M. J., 317: 703-713.

Van Epps, H. L. (2006) René Dubos: unearthing antibiotics. J. Exp. Med., 203: 259.

Vangas, G. and Stankevich, E. I. (1960) Zh. Obshch. Khim., 32: 3278, Chem. Abstr.

1961, 55: 21119.

Vries, J.G.d. and Mrsic, N. (2011) Organocatalytic asymmetric transfer

hydrogenation of imines Catal. Sci. Technol., 1: 727-735.

Wachter, G. A., Davis, M. C., Martin, A. R. and Franzblau, S. G. (1998)

Antimycobacterial Activity of Substituted Isosteres of Pyridine- and

Pyrazinecarboxylic Acids. J. Med. Chem., 41: 2436-2438.

Wainwright, M. (1989) Moulds in ancient and more recent medicine. Mycologist, 3:

21–23.

Wakchaure, V. N., Nicoletti, M., Ratjen, L. and List, B. (2010) Towards a Practical

Brønsted Acid Catalyzed and Hantzsch Ester Mediated Asymmetric Reductive

Amination of Ketones with Benzylamine. Synlett, 2708-2711.

Waksman, S. A. (1947) What Is an Antibiotic or an Antibiotic Substance?.

Mycologia, 39: 565–569.

223

Walsh, C. (2003) American Society for Microbiology Press: Washington DC.

Wang, D-W., Zeng, W. and Zhou, Y-G. (2007) Iridium-catalyzed asymmetric transfer

hydrogenation of quinolines with Hantzsch esters. Tetrahedron: Asymmetry,

18: 1103-1107.

Wang, L M., Sheng, 1., Zhang, L, Han, J. W., Fan, Z. Y., Tian, H. and Qian, C. T.

(2005) Facile Yb(OTf)3 promoted one-pot synthesis of polyhydroquinoline

derivatives through Hantzsch reaction. Tetrahedron, 61: 1539-1543.

Wang, L., Kong, F., Kokoski, C. L., Andrews, D. W. and Xing, C. (2008)

Development of dimeric modulators for anti-apoptotic Bcl-2 proteins. Bioorg.

& Med. Chem. Lett., 18: 236–240.

Wang, X-B., Zeng, W. and Zhou, Y-G. (2008) Iridium-catalyzed asymmetric

hydrogenation of pyridine derivatives, 7,8-dihydro-quinolin-5(6H)-ones.


Wang, Y. C. and Lipsitch, M. (2006) Upgrading antibiotic use within a class:

Tradeoff between resistance and treatment success. Proc. Natl. Acad. Sci.

USA, 103: 9655-9660.

Weigel, L. M. (2003) Genetic Analysis of a High-Level Vancomycin-Resistant

Isolate of Staphylococcus aureus. Science, 302: 1569-1571.

Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S.

R., Beck, K. D., Moore, L. B., Kliewer, S. A. and Lehmann, J. M. (1996) The

structure-activity relationship between peroxisome proliferator-activated

receptor γ agonism and the antihyperglycemic activity of thiazolidinediones.

J. Med. Chem., 39: 665-668.

224

Wu, Ying., Tai, H. -H. and Cho, H. (2010) Synthesis and SAR of thiazolidinedione

derivatives as 15-PGDH inhibitors. Bioorg. & Med. Chem., 18: 1428–1433.

Xia, J.-J. and Wang, G.- W. (2005) One-pot synthesis and aromatization of 1,4-

dihydropyridines in refluxing water. Synthesis, 2379-2383.

Xing, R-G., Li, Y-N., Liu, Q., Meng, Q-Y., Li, J., Shen, X-X., Liu, Z., Zhou, B., Yao,

X. and Liu, Z-Li. (2010) Facile and Efficient Synthesis of Benzoxazoles and

Benzimidazoles: The Application of Hantzsch ester 1,4-dihydropyridines in

Reductive Cyclization Reactions. Eur. J. Org. Chem., 34: 6627-6632.

Yamamoto, H., Uchigata, Y. and Okamoto, H. (1981) Streptozotocin and alloxan

induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic

islets. Nature, 294: 284-286.

Yamanoi, T., Oda, Y., Muraishi, H. and Matsuda, S. (2008) Synthesis of a novel D-

glucose-conjugated 15-crown-5 ether with a spiro ketal structure. Molecules,

13: 1840-1845.

Yang, 1. W., Fonseca, M. T. H. and Vignola, N. (2005) Metal-Free, Organocatalytic

Asymmetric Transfer Hydrogenation of a,b-Unsaturated Aldehydes Angew.

Chem. Int. Ed., 44: 108-110.

Yang, J. W. and Fonseca, M. T. H. (2004) A Metal-Free Transfer Hydrogenation:

Organocatalytic Conjugate Reduction of α,β-Unsaturated Aldehydes. Angew

Chem. Int. Ed., 43: 6660-6662. (c) Ouellet,S. G., Tuttle, J. B. and MacMillan,

D. W. C. (2005) Enantioselective organocatalytic hydride reduction. J Am.

Chem. Soc., 127: 32-33.

225

Yang, J. W. and List, B. (2006) Catalytic Asymmetric Transfer Hydrogenation of r-

Ketoesters with Hantzsch Esters. Org. Lett., 8: 5653-5655.

Yang, J. W., Fonseca, M. T. H. and List, B. (2004) A Metal-Free Transfer

Hydrogenation: Organocatalytic Conjugate Reduction of αβ-Unsaturated

Aldehydes. Angew. Chem. Int. Ed., 43: 6660-6662.

Yang, J. W., Fonseca, M. T. H. and List, B. (2005) Catalytic Asymmetric Reductive

Michael Cyclization. J. Am. Chem. Soc., 127: 15036-15037.

Yang, J. W., Fonseca, M. T. H., Vignola, N. and List, B. (2005) Metal-Free,

Organocatalytic Asymmetric Transfer Hydrogenation of αβ-Unsaturated

Aldehydes. Angew. Chem. Int. Ed., 44: 108-110.

Yoshioka, T., Fujita, T., Kanai, T., Aizawa, Y., Kurumada, T., Hasegawa, K. and

Horikoshi, H. (1989) Studies on Hindered Phenols and Analogues. 1.

Hypolipidemic and Hypoglycemic Agents with Ability to Inhibit Lipid

Peroxidation. J. Med. Chem., 32: 421-428.

Zamponi, G. W., Stotz, S. C., Staples, R. J., Andro, T. M., Nelson, J. K.,Hulubei, U.,

Blumenfeld, A. and Natale, N. R. (2003) Unique structureactivity relationship

for 4-isoxazolyl-1,4-dihydropyridines J. Med. Chem., 46: 87-96.

Zervosen, A., Lu, W. P., Chen, Z., White, R. E., Demuth, T. P., Jr. and Frere, J. M.

(2004) Interactions between penicillin-binding proteins (PBPs) and two novel

classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene

iminothiazolidin-4-ones. Antimicrob. Agents Chemother., 48: 961-969.

226

Zhang, B. B. and Muller, D. E. (2000) New approaches in the treatment of type 2

diabetes. Curr. Opin. Chem. Bio., 4: 461-467.

Zhang, B., Zhu, X-Q., Lu, J-Y., He, J., Wang, P. G. and Cheng, J-P. (2003)

Polysiloxane-Supported NAD(P)H Model 1-Benzyl-1,4-dihydronicotinamide:

Synthesis and Application in the Reduction of Activated Olefins J. Org.

Chem., 68: 3295-3298.

Zhang, J., Jin, M-Z., Zhang, W., Yang, L. and Liu, Z-L. (2002) Photoinduced

transformation of α,β-epoxyketones to β-hydroxyketones by Hantzsch 1,4-

dihydropyridine. Tetrahedron Lett., 43: 9687-9689.

Zhang, M., Yang, H., Zhang, Y., Zhu, C., Li, W., Cheng, Y. and Hua, H. (2011)

Direct reductive amination of aromatic aldehydes catalyzed by gold(I)complex

under transfer hydrogenation conditions. Chem. Commun., 47: 6605-6607.

Zhang, Z. and Schreiner, P. R. (2007) Organocatalytic Biomimetic Reduction of

Conjugated Nitroalkenes. Synthesis, 16: 2559-2564.

Zhang, Z. and Schreiner, P. R. (2009) (Thio)urea organocatalysis—What can be

learnt from anion recognition? Chem. Soc. Rev., 38: 1187-1198.

Zhao, G-L. and Cordova, A. (2006) Direct organocatalytic asymmetric reductive

Mannich-type reactions. Tetrahedron Lett., 47: 7417-7421.

Zhao, Y., Liu, Q., Li, J., Liu, Z. and Zhou, B. (2010) Highly Selective

Semihydrogenation of Phenylalkynes to (Z)-Styrenes Using Hantzsch Ester 1,

4-Dihydropyridine Catalyzed by Pd/C. Synlett, 1870-1873.

Zhou, J. and List, B. (2007) Organocatalytic Asymmetric Reaction Cascade to

Substituted Cyclohexylamines. J. Am. Chem. Soc., 129: 7498-7499.

227

Zhou, J. F., Song, Y. Z., Zhu, F. X. and Zhu, Y. L. (2006) Facile synthesis of 5-

benzylidene rhodanine derivatives under microwave irradiation. Synth.

Commun., 36: 3297–3303.

Zhou, J.-F., Zhu, F.-X., Song, Y.-Z. and Zhu, Y.-L. (2006) Synthesis of 5-

arylalkylidenerhodanines catalyzed by tetrabutylammonium bromine in water

under microwave irradiation. ARKIVOC, xiv: 175-180.

Zhu, X.-Q., Wang, H.-Y., Wang, J.-S. and Liu, Y.-C. (2001) Application of

NAD(P)H Model Hantzsch 1,4-Dihydropyridine as a Mild Reducing Agent in

Preparation of Cyclo Compounds. J. Org. Chem., 66: 344–347.

Zhu, X-Q., Zou, H-L., Yuan, P-W., Liu, Y., Cao, L. and Cheng, J-P. (2000) A

detailed investigation into the oxidation mechanism of Hantzsch 1,4-

dihydropyridines by ethyl α-cyanocinnamates and benzylidenemalononitriles.

J. Chem. Soc. Perkin Trans. 2: 1857-1861.

Ziegler, D. (2008) Treatment of diabetic neuropathy and neuropathic pain: how far

have we come? Diabetes Care, 31: S255–S261.

Date post:	01-Jan-2017
Category:	Documents
Upload:	dinhkhanh
View:	218 times
Download:	2 times

Anti-Diabetic and Antibiotic Study of Chromon-3-Ylidine 2,4 ...

Documents